Bepridil Hydrochloride

盐酸苄普地尔

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameBepridil Hydrochloride
Drug Alias NameCordium普地尔苄普地尔bepridilumangopril +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockersPotassium channel blockersVoltage-gated calcium channel blockers +[4] 
TargetsPotassium channelSodium channel alpha subunitVoltage-gated calcium channel +[4] 
Therapy Area/IndicationsAngina PectorisTachycardiaAtrial Fibrillation
Global Approved IndicationsAngina PectorisTachycardiaAtrial Fibrillation
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson
Inactive CompaniesN/A
Active IndicationsAngina PectorisTachycardiaAtrial Fibrillation
Inactive IndicationsN/A

Other Information

ATC CodeC08EA02
Related LinksWikipediaDrugBankKEGG